文献速递慢性肾脏病遗传性与小管间质肾病

Tsc1介导的mTORC1激活通过促进糖酵解推动肾纤维化

Tuberous sclerosis 1 (Tsc1) mediated mTORC1 activation promotes glycolysis in tubular epithelial cells in kidney fibrosis.
PubMed 文献 · Kidney Int · 2020-04-27

本研究探讨结节性硬化症复合物1(Tsc1)是否通过调控近端小管上皮细胞糖酵解介导肾间质纤维化进展。在单侧输尿管梗阻小鼠模型中,mTORC1激活伴小管细胞增殖和糖酵解酶上调,雷帕霉素可抑制上述效应;Tsc1敲低促进NRK-52E细胞糖酵解,近端小管Tsc1特异性缺失导致肾脏增大、小管扩张伴囊肿形成及间质纤维化,糖酵解抑制剂2-脱氧葡萄糖可改善上述病变。

要点

  • Tsc1缺失通过激活mTORC1促进近端小管上皮细胞糖酵解。
  • 糖酵解抑制剂2-脱氧葡萄糖可减轻小管增殖、囊肿形成和纤维化。

核心结论

  • Tsc1相关mTORC1信号通过调控近端小管上皮细胞糖酵解介导肾间质纤维化进展。

研究设计与样本

  • 采用单侧输尿管梗阻小鼠模型、NRK-52E细胞系及近端小管Tsc1特异性缺失小鼠进行实验研究。

主要发现

  • 单侧输尿管梗阻肾脏中mTORC1信号激活,伴小管上皮细胞增殖增加和糖酵解酶上调。
  • 雷帕霉素预处理抑制mTORC1激活,并消除增强的糖酵解和小管上皮细胞增殖。
  • Tsc1敲低促进NRK-52E细胞糖酵解。
  • 近端小管Tsc1特异性缺失小鼠表现为肾脏增大、高比例增殖性小管上皮细胞、小管扩张伴囊肿形成、大面积间质纤维化及糖酵解升高。
  • 2-脱氧葡萄糖治疗显著改善小管上皮细胞增殖、囊肿形成和肾脏纤维化。

临床怎么用

  • 提示靶向Tsc1-mTORC1-糖酵解轴可能成为延缓肾间质纤维化的潜在策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Energy reprogramming to glycolysis is closely associated with the development of chronic kidney disease. As an important negative regulatory factor of the mammalian target of rapamycin complex 1 (mTORC1) signal, tuberous sclerosis complex 1 (Tsc1) is also a key regulatory point of glycolysis. Here, we investigated whether Tsc1 could mediate the progression of kidney interstitial fibrosis by regulating glycolysis in proximal tubular epithelial cells. We induced mTORC1 signal activation in tubular epithelial cells in kidneys with fibrosis via unilateral ureteral occlusion. This resulted in increased tubular epithelial cell proliferation and glycolytic enzyme upregulation. Prior incubation with rapamycin inhibited mTORC1 activation and abolished the enhanced glycolysis and tubular epithelial cell proliferation. Furthermore, knockdown of Tsc1 expression promoted glycolysis in the rat kidney epithelial cell line NRK-52E. Specific deletion of Tsc1 in the proximal tubules of mice resulted in enlarged kidneys characterized by a high proportion of proliferative tubular epithelial cells, dilated tubules with cyst formation, and a large area of interstitial fibrosis in conjunction with elevated glycolysis. Treatment of the mice with the glycolysis inhibitor 2-deoxyglucose notably ameliorated tubular epithelial cell proliferation, cystogenesis, and kidney fibrosis. Thus, our findings suggest that Tsc1-associated mTORC1 signaling mediates the progression of kidney interstitial fibrosis by regulating glycolysis in proximal tubular epithelial cells.

来源:Kidney Int,查看原文。版权归原作者所有。

引用

  1. Cao H, Luo J, Zhang Y, et al. Tuberous sclerosis 1 (Tsc1) mediated mTORC1 activation promotes glycolysis in tubular epithelial cells in kidney fibrosis. Kidney Int. 2020. PMID: 32739207. doi:10.1016/j.kint.2020.03.035

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。